Jubilant Ingrevia augments CDMO presence with Rs 270 crore contract

18 Apr 2022 Evaluate

Jubilant Ingrevia has bagged a CDMO contract for estimated value of Rs 270 Crore in Specialty Chemicals business, spanning over a period of three years with one of its international customers, who is among the top 10 leading innovator pharmaceutical companies globally.

Through the contract the Company will supply Two key GMP intermediates for one of the ‘patented drugs’ of the Innovator Pharmaceutical customer. Both these products involve 7 steps specialised chemistry. The Company was awarded these CDMO projects few years back and with extensive work in R&D and Scale-up, it has successfully demonstrated its capability in Process development, optimisation and scaling-up of complex chemistries. Commercial supplies of both these products will start from FY’23 onwards. The Company will use GMP facility to service this contract.

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.

Jubilant Ingrevia Share Price

788.50 -50.65 (-6.04%)
08-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1003.75
SRF 2350.90
Pidilite Inds. 2908.65
Aarti Inds 398.10
Atul 6863.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.